Order of Administration of Combination Cytokine Therapies Can Decouple Toxicity From Efficacy in Syngeneic Mouse Tumor Models

OncoImmunology - United States
doi 10.1080/2162402x.2018.1558678
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Tumor Burden Affects Efficacy of Combination Immunotherapy

Cancer Discovery
Oncology
2019English

Methods for Monitoring Artemisinin-Based Combination Therapies Efficacy

Clinical Reviews and Opinions
2017English

Comparative Efficacy of Combination Bronchodilator Therapies in COPD: A Network Meta-Analysis

International Journal of COPD
EnvironmentalPublic HealthHealth PolicyMedicinePulmonaryRespiratory MedicineOccupational Health
2015English

Metabolomic Changes Accompanying Transformation and Acquisition of Metastatic Potential in a Syngeneic Mouse Mammary Tumor Model

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Cytokine Therapies in Neurological Disease

Neurotherapeutics
NeurologyPharmacology
2016English

SynToxProfiler: An Interactive Analysis of Drug Combination Synergy, Toxicity and Efficacy

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2020English

Preemptive Leucovorin Administration Minimizes Pralatrexate Toxicity Without Sacrificing Efficacy

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models

PLoS ONE
Multidisciplinary
2010English

Can Novel Therapies for Arrhythmias Caused by Spontaneous Sarcoplasmic Reticulum Ca2+ Release Be Developed Using Mouse Models?

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy